Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
8126 items from SEC EDGAR · clear filters
- 8-K/A - CANADIAN DERIVATIVES CLEARING CORP (0000319643) (Filer)
Canadian Derivatives Clearing Corp filed an amended Form 8-K on October 7, 2026 (Accession No. 0001099910-26-000272), providing Item 9.01 financial statements and related exhibits.
- 8-K - Cadrenal Therapeutics, Inc. (0001937993) (Filer)
Cadrenal Therapeutics filed a Form 8-K on October 7, 2026, containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - Angel Oak Mortgage REIT, Inc. (0001766478) (Filer)
Angel Oak Mortgage REIT filed an 8-K reporting amendments to its articles of incorporation and bylaws, including a change to its fiscal year end.
- 8-K - PULSE BIOSCIENCES, INC. (0001625101) (Filer)
Pulse Biosciences, Inc. filed a Form 8-K with the SEC on October 7, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - COFFEE HOLDING CO INC (0001007019) (Filer)
Coffee Holding Co Inc filed a Form 8-K on October 7, 2026, including Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits, with accession number 0001493152-26-046091.
- 8-K - ALKAMI TECHNOLOGY, INC. (0001529274) (Filer)
Alkami Technology, Inc. filed a Form 8-K reporting the departure of certain directors or officers, the election or appointment of new directors and officers, and disclosed compensatory arrangements for the appointed officers.
- 8-K - BioNexus Gene Lab Corp (0001737523) (Filer)
BioNexus Gene Lab Corp filed a Form 8-K on October 7, 2026, reporting a material definitive agreement, unregistered sales of equity securities, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K/A - MODINE MANUFACTURING CO (0000067347) (Filer)
Modine Manufacturing Co. filed an amended Form 8-K on October 7, 2026, under Item 9.01, providing revised financial statements and accompanying exhibits.
- 8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)
Ultragenyx Pharmaceutical Inc. filed a Form 8-K on October 7, 2026, disclosing that it has entered into a material definitive agreement.
- 8-K - Envoy Medical, Inc. (0001840877) (Filer)
Envoy Medical, Inc. filed a Form 8-K on October 7, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) with a 238-KB filing (AccNo 0001213900-26-107434).
- 8-K - Onfolio Holdings, Inc (0001825452) (Filer)
Onfolio Holdings filed an 8-K reporting a notice of delisting or failure to meet a continued listing rule and a transfer of its listing, along with other events and accompanying financial statements and exhibits.
- 8-K - BioCardia, Inc. (0000925741) (Filer)
BioCardia, Inc. filed a Form 8-K with the SEC on October 7, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - NEOGEN CORP (0000711377) (Filer)
NeoGen Corp filed an 8-K on October 7, 2026, including Item 5.07 regarding submission of matters to a vote of security holders and Item 9.01 containing financial statements and related exhibits.
- 8-K - BITMINE IMMERSION TECHNOLOGIES, INC. (0001829311) (Filer)
Bitmine Immersion Technologies, Inc. filed a Form 8-K with the SEC on October 7, 2026, containing a Regulation FD disclosure and the company’s financial statements and related exhibits.
- 8-K - AIB Data Centers Inc. (0002070542) (Filer)
AIB Data Centers Inc. filed a Form 8-K on October 7, 2026, containing a Regulation FD disclosure and the company’s financial statements and related exhibits.
- 8-K - Ellington Financial Inc. (0001411342) (Filer)
Ellington Financial Inc. filed a Form 8-K on October 7, 2026, reporting other events under Item 8.01 and providing financial statements and exhibits under Item 9.01.
- 8-K - Ellington Credit Co (0001560672) (Filer)
Ellington Credit Co filed a Form 8-K on October 7, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001628280-26-065295.
- 8-K - TaoWeave, Inc. (0000746210) (Filer)
TaoWeave, Inc. filed a Form 8-K on October 7, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Launch Two Acquisition Corp. (0002023676) (Filer)
Launch Two Acquisition Corp. filed a Form 8-K on October 7, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Filer)
CERO Therapeutics Holdings, Inc. filed a Form 8-K on October 7, 2026, disclosing entry into a material definitive agreement and including its financial statements and accompanying exhibits.
- 8-K - Beeline Holdings, Inc. (0001534708) (Filer)
Beeline Holdings, Inc. filed a Form 8-K on October 7, 2026, reporting a Regulation FD disclosure and providing its financial statements and related exhibits as required under Item 7.01 and Item 9.01.
- 8-K - BILI Social International, Inc. (0001109262) (Filer)
BILI Social International, Inc. submitted a Form 8-K filing under Item 8.01 (Other Events) on October 7, 2026, with accession number 0001683168-26-007679, comprising 186 KB of information.
- 8-K - Charlton Aria Acquisition Corp (0002024459) (Filer)
Charlton Aria Acquisition Corp filed a Form 8-K on October 7, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - OpenWorld, Inc. (0001104038) (Filer)
OpenWorld, Inc. filed a Form 8-K with the SEC on October 7, 2026, containing a Regulation FD disclosure and the company's financial statements and related exhibits.
- 8-K - MEXICO FUND INC (0000065433) (Filer)
Mexico Fund Inc filed a Form 8-K on October 7, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - FUELCELL ENERGY INC (0000886128) (Filer)
FuelCell Energy Inc. filed an 8-K reporting the departure, election, and appointment of certain directors or officers, along with related compensatory arrangements, and included its financial statements and accompanying exhibits.
- 8-K - Jasper Therapeutics, Inc. (0001788028) (Filer)
Jasper Therapeutics, Inc. filed a Form 8-K on October 7 2026 (Accession No. 0001213900-26-107402) containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - SRX Global Inc. (0001471727) (Filer)
SRX Global Inc. filed a Form 8-K on October 7, 2026, reporting entry into a material definitive agreement and including its financial statements and related exhibits.
- 8-K - WillScot Holdings Corp (0001647088) (Filer)
WillScot Holdings Corp filed a Form 8-K on Oct. 7, 2026, reporting departures, elections, appointments and related compensation arrangements for certain officers, and providing a Regulation FD disclosure.
- 8-K - Azenta, Inc. (0000933974) (Filer)
Azenta, Inc. filed a Form 8-K on October 7 2026, disclosing costs associated with exit or disposal activities, material impairments, and providing its financial statements and related exhibits.